Saturday 21 September 2019 ,
Saturday 21 September 2019 ,
Latest News
  • Now Jubo League expels Khalid
  • Jubo League leader Shamim arrested
  • PM off to New York to attend 74th UNGA
  • Drive against graft, to be continued everywhere: Quader
  • Bangladesh made strides in cutting child, maternal mortality: WHO
  • 29 million babies born into conflict in 2018: Unicef
31 July, 2019 08:46:11 AM
Print

Beximco Pharma starts export of 5th product to US

STAFF REPORTER, Dhaka
Beximco Pharma starts export of 5th product to US

The country’s leading medicine exporter Beximco Pharmaceuticals Limited has commenced export of a blood pressure drug, Nadolol, to the US market.

Nadolol tablets (20mg, 40mg and 80mg) are the generic equivalent of Bristol-Myers Squibb’s Corgard tablets for treating hypertension and angina pectoris (chest pain).

This is Beximco’s fifth product to the US market following the successful launching of Carvedilol, Sotalol, Methocarbamol and Metformin.  According to IQVIA audited data of US market, the total market for Nadolol was more than $63 million in 2018, a press statement said.

Nazmul Hassan, managing director of Beximco Pharmaceuticals, said, “We are delighted to announce the launch of Nadolol, our fifth product in the US market, which demonstrates continued progress in expanding our presence in this important market.”

“With a strong portfolio and an attractive pipeline of products in development for the US and other regulated and emerging markets, we are well positioned to continue to achieve double-digit growth in our export business,” he said.

In August 2016, Beximco Pharma became the first Bangladeshi pharmaceutical company to export medicine to the US market following its manufacturing site approval by the US FDA in June 2015, the statement said.   

BK

Comments

Video
More Business Stories
BTRC finalises guidelines to curb mobile tower radiation The Bangladesh Tele-communication Regulatory Commission (BTRC) has finalised the guidelines on limiting radiation from base transceiver stations of mobile phone operators. The BTRC, following a High Court instruction in March 2017,…

Copyright © All right reserved.

Editor : M. Shamsur Rahman

Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Editor : M. Shamsur Rahman
Published by the Editor on behalf of Independent Publications Limited at Media Printers, 446/H, Tejgaon I/A, Dhaka-1215.
Editorial, News & Commercial Offices : Beximco Media Complex, 149-150 Tejgaon I/A, Dhaka-1208, Bangladesh. GPO Box No. 934, Dhaka-1000.

Disclaimer & Privacy Policy
....................................................
About Us
....................................................
Contact Us
....................................................
Advertisement
....................................................
Subscription

Powered by : Frog Hosting